Kapil Cotex Limited Rebrands as Skybitech Healthcare Limited

Kapil Cotex Limited , a company listed on the Bombay Stock Exchange (BSE), has undergone a significant transformation with a change in its corporate identity. The company has officially rebranded itself as Skybitech Healthcare Limited, marking a new chapter in its corporate journey.

Key Details of the Name Change

Aspect	Old Information	New Information
Company Name	Kapil Cotex Limited	Skybitech Healthcare Limited
Corporate Identification Number (CIN)	L17100MH1983PLC031114	L21001MH1983PLC031114
BSE Script Code	512036	512036 (Unchanged)
Effective Date	-	November 7, 2025

Official Approval and Documentation

The company has received formal approval for this name change from the Registrar of Companies (ROC), Ministry of Corporate Affairs. A fresh Certificate of Incorporation has been issued to the company, reflecting its new identity as Skybitech Healthcare Limited.

Regulatory Compliance

In adherence to Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015, the company has duly informed the BSE Limited about this development. This timely disclosure ensures transparency and keeps all stakeholders informed about the significant change in the company's identity.

Implications for Stakeholders

It's important to note that while the company's name and CIN have changed, its BSE script code remains the same. This continuity in the script code should help maintain consistency for investors and traders dealing with the company's shares on the stock exchange.

Transition Period

As per regulatory requirements, Skybitech Healthcare Limited is obligated to display its old name (Kapil Cotex Limited) alongside the new name for a period of two years. This practice is mandated at all places where the company is required to display its name, in accordance with Section 12 of the Companies Act.

Stakeholder Advisory

The Ministry of Corporate Affairs has advised all stakeholders to verify the latest status of the company and its directors through the official MCA website ( www.mca.gov.in/MCA21 ). This recommendation underscores the importance of due diligence in light of the corporate changes.

This name change from Kapil Cotex Limited to Skybitech Healthcare Limited potentially signals a shift in the company's business focus or strategy. Stakeholders may want to keep a close eye on any further announcements or changes in the company's operations that might follow this rebranding exercise.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-4.97%	-18.44%	-28.57%	-26.28%	-42.19%	+639.20%

Kapil Cotex Limited , soon to be known as Skybiotech Healthcare Limited, held its 42nd Annual General Meeting (AGM) on September 25, 2025, marking a significant turning point for the company. Shareholders overwhelmingly approved nine resolutions, each receiving 99.99% approval from the 1,340,695 votes cast.

Key Resolutions Passed

Financial Statements Adoption: Shareholders approved the audited financial statements for the year ended March 31, 2025, including both standalone and consolidated accounts.
Director Reappointment: Mrs. Poonam Prakash Rathi was re-appointed as a director of the company.
Secretarial Auditor Appointment: M/s. SM Dhumal & Associates were appointed as the company's Secretarial Auditors.
Independent Director Appointment: Mr. Vijay Sitaram Chitlange was appointed as a Non-Executive Independent Director.
Main Object Clause Alteration: The company's Memorandum of Association saw an alteration in its main object clause, signaling a potential shift in business focus.
Company Name Change: Shareholders approved changing the company name from Kapil Cotex Limited to Skybiotech Healthcare Limited, reflecting a new direction for the firm.
Authorized Share Capital Increase: The company received approval to increase its authorized share capital, potentially paving the way for future growth and expansion.
Ratification of Share Acquisition: Shareholders ratified the acquisition of equity shares in Skybiotech Life Sciences Private Limited, which had exceeded limits under section 186(2) of the Companies Act, 2013.

Voting Details

The voting process included both remote e-voting and polling at the AGM. The results showed strong shareholder support across all resolutions:

Category	Votes Polled	Votes in Favor	Votes Against	% in Favor
Promoter and Promoter Group	1,215,575	1,215,575	0	100.00%
Public - Non Institutions	125,120	125,111	9	99.99%
Total	1,340,695	1,340,686	9	99.99%

Looking Ahead

The approval of these resolutions, particularly the name change and alteration of the main object clause, suggests a strategic shift for the company. The move from Kapil Cotex Limited to Skybiotech Healthcare Limited indicates a potential pivot towards the healthcare or biotechnology sector, which could open up new opportunities for growth and diversification.

The increase in authorized share capital and the ratification of the acquisition of Skybiotech Life Sciences Private Limited shares further underscore the company's ambitious plans for expansion and development in its new direction.

As Kapil Cotex embarks on this new chapter, stakeholders will be keen to observe how these changes translate into operational and financial performance in the coming years.